*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*                                                                     *x*
*x*            Copyright (C) 1990 University of Pennsylvania            *x*
*x*                                                                     *x*
*x*    The data in this file are part of a preliminary version of the   *x*
*x*    Penn Treebank Corpus.  Any research using this corpus or based   *x*
*x*    on it should acknowledge that fact, as well as the preliminary   *x*
*x*    nature of the corpus.                                            *x*
*x*                                                                     *x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*



======================================

[ Syncor/NNP International/NNP ]
expects/VBZ to/TO report/VB 
[ a/DT ninefold/JJ increase/NN ]
in/IN 
[ fiscal/JJ first-quarter/JJ earnings/NNS ]
on/IN 
[ a/DT 10/CD %/NN ]
to/TO 
[ 11/CD %/NN rise/NN ]
in/IN 
[ sales/NNS ]
,/, 
[ Gene/NNP R./NNP McGrevin/NNP ]
,/, 
[ president/NN ]
and/CC 
[ chief/JJ executive/JJ officer/NN ]
,/, said/VBD ./. 

======================================

[ Mr./NNP McGrevin/NNP ]
attributed/VBD 
[ the/DT sharp/JJ earnings/NNS ]
gain/NN to/TO 
[ tight/JJ cost/NN controls/NNS ]
,/, 
[ more/RBR judicious/JJ price/NN cuts/NNS ]
and/CC 
[ personnel/NNS changes/NNS ]
./. 

[ Syncor/NNP ]
,/, based/VBN in/IN 
[ Chatsworth/NNP ]
,/, 
[ Calif./NNP ]
,/, operates/VBZ 
[ 84/CD service/NN centers/NNS ]

[ which/WDT ]
prepare/VBP and/CC deliver/VBP 
[ specialty/NN radiopharmaceutical/JJ products/NNS ]
used/VBN to/TO diagnose/VB 
[ cancer/NN ]
and/CC 
[ heart/NN disease/NN ]
./. 

======================================

[ The/DT company/NN ]
expects/VBZ to/TO report/VB 
[ first-quarter/JJ earnings/NNS ]
of/IN 
[ $/$ 800,000/CD ]
to/TO 
[ $/$ 900,000/CD ]
,/, or/CC 
[ seven/CD cents/NNS ]
to/TO 
[ nine/CD cents/NNS ]

[ a/DT share/NN ]
,/, compared/VBN with/IN 
[ $/$ 95,000/CD ]
,/, or/CC 
[ one/CD cent/NN ]

[ a/DT share/NN ]
,/, 
[ a/DT year/NN ]
earlier/RBR ,/, 
[ Mr./NNP McGrevin/NNP ]
said/VBD in/IN 
[ an/DT interview/NN ]
./. 

[ Sales/NNS ]
in/IN 
[ the/DT quarter/NN ]
ended/VBN 
[ Aug./NNP 31/CD ]
are/VBP expected/VBN to/TO be/VB between/IN 
[ $/$ 29/CD million/CD ]
and/CC 
[ $/$ 30/CD million/CD ]
,/, up/RB from/IN 
[ $/$ 27.2/CD million/CD ]

[ a/DT year/NN ]
ago/RB ./. 

======================================

[ The/DT first-quarter/JJ figures/NNS ]
represent/VBP 
[ a/DT turnaround/NN ]
for/IN 
[ the/DT company/NN ]
,/, said/VBD 
[ Mr./NNP McGrevin/NNP ]
,/, 
[ who/WP ]
joined/VBD 
[ Syncor/NNP last/JJ February/NNP ]
./. 

[ Syncor/NNP ]
had/VBD been/VBN battered/VBN by/IN 
[ two/CD competitors/NNS ]

[ who/WP ]
entered/VBD 
[ the/DT radio-pharmaceutical/JJ distribution/NN business/NN ]
and/CC 
[ undercut/VBD Syncor/NNP 's/POS prices/NNS ]
to/TO gain/VB 
[ market/NN share/NN ]
./. 

[ The/DT strategy/NN ]
worked/VBD ,/, as/IN 
[ Syncor/NNP 's/POS share/NN ]
of/IN 
[ the/DT market/NN ]
was/VBD cut/VBN to/TO about/RB 
[ 50/CD %/NN ]
from/IN 
[ 80/CD %/NN ]
./. 

======================================

Now/RB ,/, by/IN 
[ reducing/VBG labor/NN ]
and/CC 
[ material/NN costs/NNS ]
,/, 
[ that/DT trend/NN ]
has/VBZ been/VBN reversed/VBN and/CC 
[ the/DT company/NN ]
holds/VBZ 
[ a/DT 60/CD %/NN market/NN share/NN ]
./. 

``/`` Before/IN ,/, 
[ our/PRP$ prices/NNS ]
and/CC 
[ market/NN share/NN ]
were/VBD going/VBG down/RB ,/, but/CC 
[ our/PRP$ costs/NNS ]
were/VBD going/VBG up/RB ./. 

[ We/PRP ]
had/VBD 
[ the/DT key/JJ indicators/NNS all/DT ]
going/VBG in/IN 
[ the/DT wrong/JJ directions/NNS ]
,/, ''/'' 
[ Mr./NNP McGrevin/NNP ]
said/VBD ./. 

======================================

[ The/DT company/NN ]
also/RB recently/RB consolidated/VBD 
[ the/DT positions/NNS ]
of/IN 
[ vice/NN president/NN ]
of/IN 
[ operations/NNS ]
and/CC 
[ vice/NN president/NN ]
of/IN marketing/NN and/CC 
[ sales/NNS ]
into/IN 
[ one/CD position/NN ]
,/, 
[ which/WDT ]

[ Mr./NNP McGrevin/NNP ]
said/VBD ``/`` eliminated/VBD 
[ a/DT lot/NN ]
of/IN 
[ internal/JJ conflict/NN ]
in/IN 
[ the/DT organization/NN ]
./. 

[ We/PRP ]
were/VBD battling/VBG 
[ ourselves/PRP ]
internally/RB more/RBR than/IN 
[ our/PRP$ competitors/NNS ]
./. 

''/'' 
======================================

[ Mr./NNP McGrevin/NNP ]
does/VBZ n't/RB expect/VB 
[ any/DT new/JJ competitors/NNS ]
to/TO emerge/VB because/IN of/IN declining/VBG 
[ returns/NNS ]
in/IN 
[ the/DT business/NN ]
./. 

Also/RB ,/, 
[ the/DT lack/NN ]
of/IN 
[ availability/NN ]
of/IN 
[ nuclear/JJ pharmacists/NNS ]
in/IN 
[ the/DT U.S./NNP ]
would/MD make/VB 
[ any/DT new/JJ player/NN unlikely/JJ ]
,/, 
[ he/PRP ]
said/VBD ./. 

Having/VBG to/TO 
[ some/DT degree/NN ]
``/`` fixed/VBN ''/'' 
[ the/DT company/NN 's/POS core/JJ business/NN ]
,/, 
[ Mr./NNP McGrevin/NNP ]
said/VBD 
[ Syncor/NNP ]
is/VBZ focusing/VBG on/IN 
[ expansion/NN ]
,/, perhaps/RB by/IN setting/VBG up/RP 
[ some/DT international/JJ medical/JJ service/NN centers/NNS ]
,/, or/CC by/IN providing/VBG 
[ other/JJ products/NNS ]
or/CC 
[ services/NNS ]
from/IN 
[ the/DT 84/CD U.S./NNP centers/NNS ]
./. 

======================================

[ The/DT company/NN ]
is/VBZ developing/VBG 
[ a/DT longrange/JJ expansion/NN plan/NN ]
,/, 
[ Mr./NNP McGrevin/NNP ]
said/VBD ./. 

To/TO be/VB able/JJ to/TO staff/VB 
[ any/DT expansion/NN ]
,/, 
[ Syncor/NNP ]
recently/RB begun/VBN 
[ a/DT recruiting/NN program/NN ]
for/IN 
[ pharmacists/NNS ]
at/IN 
[ the/DT college/NN level/NN ]
and/CC set/VBD|VBN up/RP 
[ a/DT training/NN program/NN ]
for/IN 
[ nuclear/JJ pharmacists/NNS ]
./. 

[ It/PRP ]
also/RB plans/VBZ 
[ a/DT $/$ 5/CD million/CD ]
retooling/NN of/IN 
[ the/DT company/NN 's/POS computer/NN system/NN ]
over/IN 
[ the/DT next/JJ two/CD years/NNS ]
./. 

======================================

[ The/DT company/NN ]
already/RB plans/VBZ to/TO expand/VB 
[ its/PRP$ home/NN health-care/NN services/NNS division/NN ]
,/, 
[ which/WDT ]
provides/VBZ 
[ intravenous/JJ services/NNS ]
./. 

[ The/DT division/NN ]
currently/RB has/VBZ 
[ 18/CD locations/NNS ]
and/CC 
[ its/PRP$ sales/NNS ]
should/MD expand/VB to/TO 
[ $/$ 12/CD million/CD this/DT year/NN ]
from/IN 
[ $/$ 7/CD million/CD last/JJ year/NN ]
,/, 
[ Mr./NNP McGrevin/NNP ]
said/VBD ./. 

[ The/DT company/NN ]
also/RB expects/VBZ to/TO add/VB 
[ four/CD ]
to/TO 
[ eight/CD new/JJ locations/NNS ]
in/IN 
[ this/DT division/NN ]
./. 

======================================

[ Syncor/NNP ]
also/RB is/VBZ awaiting/VBG 
[ the/DT release/NN ]
of/IN 
[ several/JJ new/JJ products/NNS ]
./. 

[ It/PRP ]
anticipates/VBZ introducing/VBG within/IN 
[ the/DT next/JJ few/JJ years/NNS ]

[ a/DT new/JJ brain/NN scan/NN product/NN ]
,/, 
[ two/CD cardiac/JJ scan/NN products/NNS ]
and/CC 
[ some/DT monoclonal/JJ products/NNS ]
./. 

======================================

[ Mr./NNP McGrevin/NNP ]
reiterated/VBD that/IN because/IN 
[ the/DT company/NN ]
is/VBZ focusing/VBG on/IN 
[ growth/NN ]
and/CC 
[ its/PRP$ competition/NN ]
,/, 
[ Syncor/NNP ]
is/VBZ not/RB for/IN 
[ sale/NN ]
./. 

Earlier/RBR 
[ this/DT month/NN ]
,/, 
[ Van/NNP Kampen/NNP Merritt/NNP ]
,/, 
[ an/DT investment/NN banking/NN unit/NN ]
of/IN 
[ Xerox/NNP Corp./NNP ]
,/, announced/VBD 
[ a/DT bid/NN ]
to/TO buy/VB 
[ Syncor/NNP 's/POS ]
for/IN about/RB 
[ $/$ 81.8/CD million/CD ]
,/, but/CC 
[ it/PRP ]
dropped/VBD 
[ the/DT bid/NN ]
due/RB to/TO 
[ Syncor/NNP 's/POS lack/NN ]
of/IN 
[ interest/NN ]
./. 

Earlier/RBR 
[ this/DT week/NN ]
,/, 
[ Syncor/NNP ]
announced/VBD 
[ it/PRP ]
would/MD buy/VB back/RP about/RB 
[ 15/CD %/NN ]
of/IN 
[ its/PRP$ outstanding/JJ stock/NN ]
from/IN 
[ a/DT French/JJ shareholder/NN ]
./. 
